Parovirus B19 VLP VP1/Vp2 Co Capsid - IgG

Elevated levels of Parvovirus B19 VLP VP1/VP2 co-capsid IgG antibodies typically indicate a past or recent infection with Parvovirus B19. The presence of IgG antibodies suggests that the individual has been exposed to the virus in the past and has developed an immune response against it. Parvovirus B19 is known to elicit both IgG and IgM responses, with IgG antibodies primarily targeting the capsid proteins VP1 and VP2.

The persistence of these antibodies can provide immunity against future infections by the same virus. However, in some cases, elevated IgG levels might also be an indication of a current or persistent infection.

Note: Further clinical evaluation, including the assessment of clinical symptoms and other laboratory findings, is necessary to determine the specific implications of the elevated IgG levels.

Lyme disease and Parovirus B19 infections produce arthritis, rashes, and a systemic illness that may be thought to represent a chronic rheumatic disease. Cases of co infections have also been reported in literature. Additionally, it has been shown to be a good candidate for differential diagnosis in cases of arthopathy where Lyme disease has been suspected.